3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Oropharyngeal Neoplasms
11
Lung Neoplasms
8
Laryngeal Neoplasms
8
Carcinoma
8
Mouth Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Hypopharyngeal Neoplasms
6
Nasopharyngeal Carcinoma
5
Mesothelioma, Malignant
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Triple Negative Breast Neoplasms
2
Salivary Gland Neoplasms
2
Paranasal Sinus Neoplasms
2
Ovarian Neoplasms
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Interventions
Cyclophosphamide
27
fludarabine
19
Dexamethasone
18
pembrolizumab
12
Rituximab
12
Etoposide
11
venetoclax
10
pomalidomide
9
Gemcitabine
9
Lenalidomide
8
fludarabine phosphate
7
daratumumab
7
Bortezomib
7
glofitamab
6
carfilzomib
6
Vincristine
6
obinutuzumab
5
Temozolomide
5
Prednisone
5
Nivolumab
5
Immunotherapy, Adoptive
5
Doxorubicin
5
Cytarabine
5
Cisplatin
5
Calcium Dobesilate
5
selinexor
4
cemiplimab
4
Carboplatin
4
Azacitidine
4
zanubrutinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
1,2-diaminocyclohexaneplatinum II citrate
×
90 days
×
Clear all
No trials found.